论文部分内容阅读
目的观察放化疗加中药综合治疗食管癌术后患者的生存期。方法本组共94例患者,随机分为治疗组48例和对照组46例,治疗组予中西医结合治疗,对照组予单纯化疗。结果治疗组2 a、5 a生存率分别为67%和25%;对照组分别为48%和43%,治疗组生存率明显高于对照组。结论提示中医中药加放化疗综合治疗食管癌术后患者的生存期优于单纯放化疗治疗者。
Objective To observe the survival of esophageal cancer patients treated with radiotherapy and chemotherapy combined with traditional Chinese medicine. Methods A total of 94 patients in this study were randomly divided into treatment group (n = 48) and control group (n = 46). The treatment group was given Integrative Medicine and the control group was treated with chemotherapy alone. Results The survival rates at 2 and 5 years in the treatment group were 67% and 25%, respectively. The control group was 48% and 43% respectively. The survival rate of the treatment group was significantly higher than that of the control group. Conclusions suggest that traditional Chinese medicine combined with chemotherapy combined treatment of esophageal cancer patients after surgery survival is better than simple radiotherapy and chemotherapy.